HKPD — Hong Kong Pharma Digital Technology Holdings Income Statement
0.000.00%
Last trade - 00:00- $12.21m
- $14.30m
- $16.69m
- 13
- 89
- 12
- 30
Annual income statement for Hong Kong Pharma Digital Technology Holdings, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2023 March 31st | 2024 March 31st | |
|---|---|---|
| Period Length: | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS |
| Standards: | IFRS | IFRS |
| Status: | Final | Final |
| Revenue | ||
| Total Revenue | 12.6 | 16.7 |
| Cost of Revenue | ||
| Gross Profit | 2.74 | 3.56 |
| Selling / General / Administrative Expenses | ||
| Unusual Expense / Income | ||
| Other Operating Expenses | ||
| Total Operating Expenses | 11.5 | 15.1 |
| Operating Profit | 1.04 | 1.61 |
| Total Net Non Operating Interest Income / Expense | ||
| Net Income Before Taxes | 1.02 | 1.53 |
| Provision for Income Taxes | ||
| Net Income After Taxes | 0.998 | 1.33 |
| Net Income Before Extraordinary Items | ||
| Net Income | 0.998 | 1.33 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||
| Income Available to Common Shareholders Including Extraordinary Items | ||
| Diluted Net Income | 0.998 | 1.33 |
| Diluted Weighted Average Shares | ||
| Basic EPS Including Extraordinary Items | ||
| Diluted EPS Including Extraordinary Items | ||
| Diluted EPS Excluding Extraordinary Items | ||
| Normalised Income Before Taxes | ||
| Normalised Income After Taxes | ||
| Normalised Income Available to Common Shareholders | ||
| Diluted Normalised EPS | 0.091 | 0.121 |
| Dividends per Share |